C. Collette Corser

Associate

vCard

C. Collette Corser

Associate

+1 202 408 6052 +1 202 408 6052
collette.corser@finnegan.com collette.corser@finnegan.com

901 New York Avenue, NW
Washington, DC 20001-4413

vCard

Show C.'s work in

Collette Corser focuses her practice on patent litigation and client counseling in various technical areas, with an emphasis on the chemical and pharmaceutical industries.

Collette is involved in all aspects of patent litigation, having gained experience serving as a judicial law clerk at the U.S. District Court for the Eastern District of Virginia. Collette's work includes pre-litigation analysis, fact and expert discovery, claim construction, motions practice, and handling day-to-day litigation activities. She has experience with Section 337 investigations before the U.S. International Trade Commission (ITC), as well as post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO).

In addition to her litigation practice, Collette counsels clients on patent portfolio management and assists with the prosecution of chemical patents.

Et Cetera

Capital Pro Bono Honor Roll, 2023.
Judicial law clerk to the Honorable John F. Anderson at the U.S. District Court for the Eastern District of Virginia, 2016–2017.
Notes editor, North Carolina Journal of Law and Technology, 2015–2016.

Experience

Rocket Pharmaceuticals, Inc. v. Lexeo Therapeutics, Inc., et al.

Represented Rocket Pharmaceuticals, Inc. in district court litigation involving claims of trade secret misappropriation and breach of contract against individual and corporate defendants and relating to complex treatments for genetic disorders. Successfully opposed motion to dismiss key claims and obtained settlement with all defendants following completion of fact discovery.

1:23-cv-09000, S.D.N.Y., Judges Castel, Aaron

In a rare rehearing proceeding, successfully represented petitioner Incyte in an inter partes review (IPR) challenging the validity of Concert’s patent before the Patent Trial and Appeal Board (PTAB). Continued representation of appellee Incyte before the Federal Circuit and secured a unanimous affirmance of the PTAB’s obviousness determination.

IPR2017-01256, PTAB, Judges Fitzpatrick, Hulse, Yang, Smith, Franklin
19-2011, Fed. Cir., Judges Hughs, Linn, Stark

Represented Vifor and American Regent in two Hatch-Waxman Act cases against Mylan and Sandoz regarding their attempts to obtain FDA approval for their respective ANDAs directed to generic copies of Injectafer®. After a six-day bench trial, the cases resulted in a favorable settlement for our clients with a generic entry date well past the expiration of the composition patents.

3:19-cv-13955, 3:19-cv-16305, D.N.J., Judges Wolfson, Arpert

Insights

At the PTAB Blog

10X Genomics Inc. v. Bio-Rad Labs., Inc.: PTAB Reiterates Patent Owner’s Obligation to Notify Board of Reexamination and Reissue 10X Genomics Inc. v. Bio-Rad Labs., Inc.: PTAB Reiterates Patent Owner’s Obligation to Notify Board of Reexamination and Reissue

May 25, 2021

Books

ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators, Third Edition ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators, Third Edition

June 16, 2020

Prosecution First Blog

Having Your Cake and Eating It Too: Considerations From Broad Claims Without Back-up Narrow Claims Having Your Cake and Eating It Too: Considerations From Broad Claims Without Back-up Narrow Claims

August 1, 2019

Prosecution First Blog

The Amazing Story of the Unsinkable Claim 8: How Many Lives Does a Patent Claim Have? The Amazing Story of the Unsinkable Claim 8: How Many Lives Does a Patent Claim Have?

July 11, 2019

Prosecution First Blog

A Tale of Two Supplemental Examinations, Part II: Surprising Events When Citing Art That, but for a Clerical Error, Would Have Been Cited During Original Prosecution A Tale of Two Supplemental Examinations, Part II: Surprising Events When Citing Art That, but for a Clerical Error, Would Have Been Cited During Original Prosecution

June 12, 2019

Prosecution First Blog

Smarmy Behavior Not Enough for Walker Process Fraud

June 6, 2019

News

Announcement

Finnegan Announces 2024 Mentors of the Year Finnegan Announces 2024 Mentors of the Year

December 31, 2024

Award/Ranking

60 Finnegan Attorneys Named to 2023 Capital Pro Bono Honor Roll

May 15, 2024

Press Release

46 Finnegan Attorneys Named to 2021 Capital Pro Bono Honor Roll 46 Finnegan Attorneys Named to 2021 Capital Pro Bono Honor Roll

June 3, 2022

Press Release

55 Finnegan Attorneys Named to 2020 Capital Pro Bono Honor Roll 55 Finnegan Attorneys Named to 2020 Capital Pro Bono Honor Roll

April 2, 2021

Press Release

62 Finnegan Attorneys Named to 2019 Capital Pro Bono Honor Roll 62 Finnegan Attorneys Named to 2019 Capital Pro Bono Honor Roll

June 8, 2020

Professional Activities

North Carolina Bar Association

Admissions and Education

Admissions

U.S. Patent and Trademark Office
District of Columbia
North Carolina

U.S. Court of Appeals, Federal Circuit

Education

University of North Carolina School of Law: J.D., with honors, 2016

University of North Carolina at Chapel Hill: B.A., Spanish, 2013

University of North Carolina at Chapel Hill: B.A., Chemistry, 2013

Clerkships

U.S. District Court, E.D. Virginia, Hon. John F. Anderson

C.'s Practices

Global IP Enforcement, Litigation, and Trials: Branded Hatch-Waxman (ANDA) Litigation and Trials; Federal Circuit and Supreme Court Appeals; ITC Section 337 Investigations and Trials; Patent Litigation and Trials; Pretrial Strategies
Patent Office Invalidation Proceedings: PTAB Invalidation Proceedings: IPR and PGR
Prosecution and Portfolio Management: Patent Drafting and Prosecution; Trade Secrets

C.'s Industries

Chemicals, Industrials, and Materials: Chemical
Life Sciences: Biologics; Biotechnology; Pharmaceutical